For over 30 years, Healius has led the way in supporting quality, affordable and accessible healthcare for all Australians.
A diverse, high performing portfolio
Healius has leading market positions and with a continued focus on margin improvement, organic growth and investment in information technology infrastructure, Healius represents an exciting opportunity for investors both now and in the future.
A formidable industry presence nationwide
Healius is one of the country's largest pathology providers, with one in every three pathology samples taken and tested in our laboratories.
A strong underlying demand
This development is influenced by trends in:
On-going population and life expectancy growth
Improving survival rates from common diseases and improving treatment options
Emergence of new diseases and pandemics
Increasingly informed and empowered consumers demanding better ways of accessing healthcare when, where and how they want it
Private health insurers and government looking for more cost efficient methods of surgery and healthcare delivery
Artificial intelligence (AI), robotics and big data analysis
Government
This is why the core of Healius’ strategy is to support the delivery of good health outcomes for patients and attractive investment and growth opportunities for our shareholders.
.png)
.png)
.png)